Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States
- Resource Type
- Article
- Source
- In
Value in Health February 2024 27(2):153-163 - Subject
- Language
- ISSN
- 1098-3015